Advisor Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Advisor Group's PFE Position: Q4 2019 in Review
Advisor Group increased its Pfizer (PFE) stake by 0.92% in Q4 2019, buying an estimated $238K and bringing the position to 733,280 shares worth $27.3M. The position accounts for 0.19% of the portfolio, ranked #99.
Advisor Group first reported a position in PFE in Q2 2016 and has held it in 15 quarters since. The position peaked at $27.9M in Q2 2019. 2,524 funds tracked by Wall St. Rank hold PFE as of Q4 2019.
- Advisor Group held 733,280 shares of Pfizer worth $27.3M as of Q4 2019.
- Advisor Group bought 6,672 Pfizer shares in Q4 2019, an estimated $238K.
- Pfizer made up 0.19% of Advisor Group's portfolio in Q4 2019, its #99 holding.
- Advisor Group first reported a position in Pfizer in Q2 2016 and has held it in 15 quarters since.
- Advisor Group's Pfizer position peaked at $27.9M in Q2 2019.
- 2,524 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.
Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.